The Central Board of Excise and Customs (CBEC) has withdrawn customs duty exemption on the import of 74 drugs, including the ones used for treating HIV and cancer. This will reportedly result in a sharp rise in the price of these drugs. Analysts said the move is "intended to provide protection to the domestic manufacturing industry". 